← Open Payments lookup

KEISHA MACK: Open Payments

NPI 1487964631 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$400 in 13 payments from 5 companies in 2025. Trend: 2023 $48 · 2024 $171 · 2025 $400

Food & beverage: $400
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$194
Neurocrine BioSciences, Inc.3$93
ACADIA Pharmaceuticals Inc4$76
AstraZeneca Pharmaceuticals LP1$20
Novo Nordisk Inc1$18

Products named: COBENFY, INGREZZA, NUPLAZID, FARXIGA, Ozempic.

Industry payments across NY — which companies pay providers there.